We've found
184,457
clinical trials
We've found
184,457
clinical trials
Glioblastoma Multiforme Clinical Trial
Updated: 12/31/1969
Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas (INTELLANCE 2)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Apnea, Sleep Clinical Trial
Updated: 7/12/2017
Radiofrequency Ablation for Multi-level Obstructive Sleep Apnea: A Single-arm, Multicenter Study
Status: Enrolling
Updated: 7/12/2017
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Infection Clinical Trial
Updated: 12/12/2016
IrrSept vs. Standard of Care in Prevention of Surgical Site Infections
Status: Enrolling,
Phase
IV
Updated: 12/12/2016
Click here to add this to my saved trials

Bleeding Clinical Trial
Updated: 12/31/1969
A Study in Patients With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Venous Leg Ulcers Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Venous Leg Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials

Venous Leg Ulcers Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Venous Leg Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials

Venous Leg Ulcers Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Venous Leg Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials

Venous Leg Ulcers Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Venous Leg Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials

Venous Leg Ulcers Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Venous Leg Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials

Pressure Ulcer Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Pressure Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials

Pressure Ulcer Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Pressure Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials

Pressure Ulcer Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Pressure Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials

Pressure Ulcer Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Pressure Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials

Pressure Ulcer Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Pressure Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials

Diabetic Foot Ulcers Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials

Diabetic Foot Ulcers Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials

Diabetic Foot Ulcers Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials

Diabetic Foot Ulcers Clinical Trial
Updated: 1/23/2018
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling,
Phase
IV
Updated: 1/23/2018
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 11/30/2016
ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies
Status: Enrolling,
Phase
I, II
Updated: 11/30/2016
Click here to add this to my saved trials

Advanced Cancer Clinical Trial
Updated: 12/31/1969
Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Advanced Cancer Clinical Trial
Updated: 12/31/1969
Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 3/23/2017
A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies
Status: Enrolling,
Phase
I
Updated: 3/23/2017
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 3/23/2017
A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies
Status: Enrolling,
Phase
I
Updated: 3/23/2017
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Neuropathic Diabetic Ulcer - Foot Clinical Trial
Updated: 4/5/2016
A Multi-Center, Prospective, Open Label Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers.
Status: Enrolling,
Phase
II
Updated: 4/5/2016
Click here to add this to my saved trials

Juvenile Idiopathic Arthritis Clinical Trial
Updated: 12/31/1969
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Juvenile Idiopathic Arthritis Clinical Trial
Updated: 12/31/1969
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Juvenile Idiopathic Arthritis Clinical Trial
Updated: 12/31/1969
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Juvenile Idiopathic Arthritis Clinical Trial
Updated: 12/31/1969
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Non-Small-Cell Lung Carcinoma Clinical Trial
Updated: 9/30/2015
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Status: Enrolling,
Phase
III
Updated: 9/30/2015
Click here to add this to my saved trials

Non-Small-Cell Lung Carcinoma Clinical Trial
Updated: 9/30/2015
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Status: Enrolling,
Phase
III
Updated: 9/30/2015
Click here to add this to my saved trials

Non-Small-Cell Lung Carcinoma Clinical Trial
Updated: 9/30/2015
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Status: Enrolling,
Phase
III
Updated: 9/30/2015
Click here to add this to my saved trials

Non-Small-Cell Lung Carcinoma Clinical Trial
Updated: 9/30/2015
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Status: Enrolling,
Phase
III
Updated: 9/30/2015
Click here to add this to my saved trials

Non-Small-Cell Lung Carcinoma Clinical Trial
Updated: 9/30/2015
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Status: Enrolling,
Phase
III
Updated: 9/30/2015
Click here to add this to my saved trials

Refractory Hurthle Cell Thyroid Cancer Clinical Trial
Updated: 12/31/1969
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Follicular Lymphoma Clinical Trial
Updated: 11/2/2015
Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
Status: Enrolling,
Phase
III
Updated: 11/2/2015
Click here to add this to my saved trials

Follicular Lymphoma Clinical Trial
Updated: 11/2/2015
Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
Status: Enrolling,
Phase
III
Updated: 11/2/2015
Click here to add this to my saved trials

Follicular Lymphoma Clinical Trial
Updated: 11/2/2015
Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
Status: Enrolling,
Phase
III
Updated: 11/2/2015
Click here to add this to my saved trials

Follicular Lymphoma Clinical Trial
Updated: 11/2/2015
Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
Status: Enrolling,
Phase
III
Updated: 11/2/2015
Click here to add this to my saved trials

Neoplasms Clinical Trial
Updated: 12/31/1969
A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Neoplasms Clinical Trial
Updated: 12/31/1969
A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Neoplasms Clinical Trial
Updated: 12/31/1969
A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Acute Oral Mucositis Pain Clinical Trial
Updated: 8/4/2015
Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy
Status: Enrolling,
Phase
III
Updated: 8/4/2015
Click here to add this to my saved trials

Compliance With Restrictive RBC Transfusion Guideline Clinical Trial
Updated: 7/20/2015
Trial of Feedback on Blood Use
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 4/26/2017
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 4/26/2017
Click here to add this to my saved trials
